Apyx Medical Corporation APYX Surgical Aesthetics — Sales Commissions And Fees
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Apyx Medical Corporation in its filing.
Tagged under the XBRL concept us-gaap:SalesCommissionsAndFees.
The official record: Apyx Medical Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apyx Medical Corporation's surgical aesthetics — sales commissions and fees.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Apyx Medical Corporation's surgical aesthetics — sales commissions and fees?
- Apyx Medical Corporation (APYX) reported surgical aesthetics — sales commissions and fees of $1.07M in Q1 2026.
- What does surgical aesthetics — sales commissions and fees mean?
- This metric tracks the variable costs associated with compensating sales personnel and third-party agents for generating revenue within the Surgical Aesthetics segment. It reflects the efficiency and cost-to-acquire dynamics of the segment's sales distribution model.